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ABSTRACT 
 
The aim of this dissertation is to legally analyse whether personal information concerning 
gamete donors can be traded in South Africa, particularly by South African gamete banks and 
agencies. As business enterprises, gamete banks and agencies may view such trade as a 
profitable business model which provides them with a competitive edge in the fertility 
industry. However, absence of regulation in this regard has caused legal uncertainty for those 
banks and agencies who wish to engage such a business model. In this desktop-based 
research, it was found that: 
 Autonomy is a key bioethical factor in the consideration of whether personal 
information should be offered to prospective parents by gamete banks and agencies. 
In particular, a significant amount of donor information acts as an autonomy-
enhancing tool for prospective parents during the donor selection process, and thus 
South African gamete banks and agencies should be allowed to offer such information 
as an optional extra. 
 Comparator countries such as the United States of America, United Kingdom and 
Canada deal with the provision of gamete donor information differently to South 
Africa. Many gamete banks and agencies in these countries provide prospective 
parents with detailed donor information without compromising donor anonymity. 
Furthermore, many of these gamete banks and agencies provide a basic donor profile 
free of charge, while charging a fee for access to extra detailed donor information. 
 South Africa can, in principle, allow the trade of personal gamete donor information.  
As it is established that trade in personal gamete donor information is permissible, this must 
be made clear to eradicate any uncertainty experienced by South African gamete banks and 
agencies. Furthermore, there should be safeguard mechanisms in place to guard against undue 
enticement of donors with regard to profit-making in the sale of donor information. 
Therefore, the following recommendations are advised: 
 A minor amendment in section 60(3) of the National Health Act.  
 Promoting donor autonomy by strengthening the informed consent mechanism. This 
can be done via state regulations concerning donor-counselling or guidelines issued 
by SASREG. 
v 
 
 Offer donors modest compensation for the provision of their personal information; 
such compensation may be determined through guidelines issued by SASREG. 
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CHAPTER 1 – INTRODUCTION 
1.1 Introduction 
Meet Margaret, a 35 year old South African doctor who owns a small family practice. She 
and her husband Michael have been trying to have a child for the past three years, but after 
countless unsuccessful attempts, Margaret decided that it was time for them to visit a fertility 
specialist. Michael has been diagnosed with azoospermia, a male medical condition 
characterised by the semen being devoid of sperm cells.  After deliberating over all their 
options going forward, Margaret and Michael decided to try conceiving through donor sperm. 
Unfortunately, none of the South African sperm banks they have researched offer an amount 
of donor information that they deem as adequate to make an informed choice. As a result, 
Margaret and Michael had to purchase and import sperm from an international sperm bank 
that offered a significant amount of non-identifying donor information – a rather costly affair. 
Now, with a healthy baby girl who recently celebrated her first birthday, it is Margaret’s 
dream to eventually open either a sperm or egg bank to help other infertile South Africans 
realise their dreams of becoming parents. While she is aware that donor anonymity is 
protected in South Africa, Margaret wishes to follow a certain business model (similar to that 
of some international gamete banks and agencies) where basic biographical information 
concerning the donor is provided free of charge, and extra non-identifying information (such 
as handwriting samples, audio clips etc) is provided at a fee. She wants to prevent other 
prospective parents from having to incur great expense in importing gametes from abroad, 
simply because those international gamete banks offer the option of purchasing extra donor 
information such as handwriting samples, audio clips etc, whereas none of the South African 
gamete banks do. She feels, however, that she requires legal certainty regarding this aspect 
before proceeding with her business endeavour. 
 
1.2 Definitions 
1.2.1 Gametes 
Gametes are sex cells that possess 50 per cent of the genetic material necessary to form a 
complete being.
1
 In terms of National Health Act 61 of 2003 (‘the NHA’), the term ‘gamete’ 
                                                          
1
 ‘Gamete’ available at https://www.britannica.com/science/gamete, accessed on 24 September 2017. 
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is defined as ‘either of the two regenerative cells essential for human reproduction’. 
Therefore, a sperm cell is a male gamete and an egg cell is a female gamete.  
1.2.2 Gamete donor v gamete recipient 
The Regulations Relating to Artificial Fertilisation of Persons
2
 (‘the Regulations’) in terms of 
the NHA, define a gamete donor as a ‘living person from whose body a gamete or gametes 
are removed or withdrawn, for the purpose of artificial fertilisation’.3 The Regulations also 
define a gamete recipient as a woman who will be artificially fertilised, or whose womb will 
house an embryo.
4
 
1.2.3 Gamete bank v gamete agency 
When prospective parents decide to use a gamete from a donor, the gamete has to be sourced 
from a third part supplier ie a gamete agency or gamete bank.
5
 Although both gamete 
agencies and banks recruit potential gamete donors, the essential difference between agencies 
and banks is that agencies merely match prospective parents to the donors, while banks go on 
to collect and store gametes which are then available for immediate use.
6
 
1.2.4 Required Information v Additional Information  
This definition has been extracted from the founding affidavit in the Nurture case. Required 
Information is a reference to the exhaustive list of gamete donor information that is legally 
required to be disclosed to recipients, as per Regulation 9(2)(b) of the Regulations.
7
 
Conversely, Additional Information is a reference to any other personal yet non-identifying 
gamete donor information falling outside the ambit of Regulation 9(2)(b) ie information that 
is not legally required.
8
  
 
1.3 The discussion 
Androcryos; Gift ov life; Nurture Egg Donors CC (‘Nurture’); Aevitas Sperm Bank; 
Medfem; and Vitalab Egg Donation Agency. These names represent a random selection of 
some South African gamete banks and agencies. A cursory view of each of these institutions’ 
websites reveals two common themes – none of these banks and agencies sells donor 
                                                          
2
 GN R1165 GG 40312, 30 September 2016. 
3
 The Regulations, 33. 
4
 Ibid. 
5
 Founding affidavit para 17 p15. 
6
 Founding affidavit para 18 p15. 
7
 Founding affidavit para 51 p32. 
8
 Founding affidavit para 63 p37. 
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information to prospective parents, and not many of these institutions even offer an extensive 
amount of donor information as compared to some international gamete banks and agencies. 
Of course, each institution offers prospective parents a limited amount of basic biographical 
information (with slight variations) about potential donors, such as age, height, mass, eye 
colour etc as this is in direct compliance with the primary legislation pertaining to gamete 
donation in South Africa – the NHA and the Regulations. Regulation 9(2)(b) requires that 
this exhaustive list of basic biographical donor information be disclosed to gamete recipients. 
Furthermore, Regulation 9(2)(b) works in accordance with Regulation 19 which ensures the 
legal protection of gamete donor anonymity. However, what should be made of non-
identifying donor information that falls outside the ambit of Regulation 9(2)(b)? Furthermore, 
what should gamete banks and agencies do if they wish to provide extra non-identifying 
donor information at a fee to gamete recipients?   
Consider, for example, the Fairfax Cryobank in the United States of America (‘USA’) which 
is a sperm bank.
9
 With regard to their anonymous donors, the Fairfax Cryobank allows 
prospective parents to browse through summary donor profiles, medical history (including 
that of the donor’s family), childhood photographs, staff impressions, donor essays, audio 
clips etc, free of charge.
10
 If, however, prospective parents wish to access further detailed 
non-identifying information about the donor (such as a personal profile, full audio interview, 
personality test results etc), they would have to purchase a package option to gain such access 
(the cost depends on the package option the prospective parents want to purchase).
11
  
Currently, the NHA outlaws the trade in gametes, as per section 60(4)(b). However, both the 
NHA and its Regulations are silent with regard to the trade in gamete donor information. The 
Southern African Society of Reproductive Medicine and Gynaecological Endoscopy 
(‘SASREG’) offers the most influential (though not legally binding) guidelines and 
recommendations pertaining to reproduction and surrounding issues. However, even 
SASREG does not address this lacuna in the law. At most, SASREG’s Guidelines for Egg 
Donation Agencies stipulate that no identifying information about the donor can be revealed 
to prospective parents, but it does allow photographs of egg donors up until the age 10 years 
to be provided to prospective parents.
12
 Thus, nothing in SASREG’s Guidelines precludes 
                                                          
9
 See https://fairfaxcryobank.com/, accessed 10 October 2017. 
10
 Ibid. 
11
 Ibid. 
12
 https://ifaasa.co.za/fertility-treatment/newsletter_02_2015_egg_donation_guidelines/, accessed on 10 
October 2017. 
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other non-identifying information from being disclosed to prospective parents, let alone being 
sold to them. As such, the overall lack of regulation with regard to the trade in gamete donor 
information paints a grey area for gamete agencies and banks wishing to engage with such a 
business model. 
The issue of trade in gamete donor information, however, was recently the subject of a South 
African High Court application: Nurture Egg Donors CC v Minister of Health
13
 (‘the Nurture 
case’). Regrettably, the application was withdrawn after litis contestatio, therefore, there will 
not be any judgment in this matter. Nevertheless, the extensive papers
14
 filed in this matter 
are in the public domain. In the fourth chapter of this dissertation, I analyse the papers filed in 
the Nurture case. For now, the following synopsis of the Nurture case will suffice:  
The applicant (Nurture), a South African egg donation agency, applied to Court concerning 
the issue of whether gamete banks could provide Additional Information
15
 to prospective 
parents at a profit. Nurture stated that it intended to establish an egg bank in South Africa – 
independent of any fertility clinic and hence, a first of its kind in South Africa. However, it 
stated that as it is a good corporate citizen, it was prudent to first seek legal certainty as to 
whether it could follow the international business model of offering Additional Information 
to prospective parents at a profit. In support of its position that Additional Information can be 
freely traded, Nurture first highlighted the conceptual difference between donor gametes and 
donor information, and argued that while trade in gametes is prohibited, no similar 
prohibition is applicable to donor information. Secondly, it differentiated between Required 
Information and Additional Information, and conceded that the provision of Required 
Information is integral to the gamete provision transaction and consequently subject to the 
same trade ban; the provision of Additional Information, on the other hand, is an optional 
extra relative to the gamete provision transaction, and therefore sufficiently removed from the 
latter not to be affected by its trade ban. 
The respondents (Minister of Health, Director-General of the National Department of Health, 
and the National Director of Public Prosecutions) opposed the application on four grounds. 
Their core argument was that although the provision of Additional Information is an optional 
                                                          
13
 (82891/15) [2016] ZAGPPHC 185. 
14
 This a reference to the Notice of Motion, Founding Affidavit, Interim Judgment, Answering Affidavit and 
Replying Affidavit. 
15
 Examples of Additional Information include childhood photographs, audio clips, handwriting samples, donor 
essays etc. 
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extra, it is dependent on the provision of gametes and therefore sufficiently proximate to the 
latter to be affected by its trade ban.  
To this argument, the applicant replied that if the respondents’ argument is accepted, it would 
render unlawful all commercial acts that are factually connected with, but do not amount to 
gamete donation. Examples of such commercial activities that were used by the applicant 
include ‘(a) the laboratory consumables supplier that provides the plastic straws in which the 
gametes are kept, and (b) the courier service that handles the transport of gametes.’16 The 
applicant argued that this consequence – rendering unlawful all commercial acts that are 
factually connected with, but do not amount to gamete donation – was clearly not the 
intention of the legislature.  
 
1.4 Statement of purpose 
The analysis concerns whether Additional Information can, as averred by Nurture, be legally 
traded in South Africa. The fact that Nurture had instituted a High Court application shows 
that there is an interest in trading in Additional Information, and is hence a proper and topical 
subject for legal investigation. 
 
1.5 Research questions  
 What is the psychological underpinning of prospective parents wanting personal 
gamete donor information? 
 How do countries such as the USA, United Kingdom (‘UK’) and Canada deal with 
the provision of donor information? 
 Should South Africa legally allow trade in personal information regarding human 
gamete donors? 
 
1.6 Research methodology 
The research methodology is desk-top based. Sources that will be consulted include primary 
sources (cases and legislation) and secondary sources (journal articles, text books, text books 
chapters and internet articles).  
                                                          
16
 Replying affidavit para 42 p12. 
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Initially, the dissertation will analyse the motivations and experiences of prospective parents 
wanting personal donor information. This sets the tone for the remainder of the dissertation, 
as this will illustrate that there is a general need by prospective parents for the option of 
accessing Additional Information. Thereafter, a comparative study will be undertaken with 
the USA, UK and Canada with regard to the provision of personal donor information. This 
will include the analysis of the laws and practices of the aforementioned countries and their 
gamete agencies/banks respectively, as they all protect donor anonymity (albeit in varying 
degrees). This chapter will also serve as a contrasting background for Chapter 4, which will 
discuss the status quo in South Africa with regard to trade in personal gamete donor 
information. Here, South African law will be discussed and analysed, in addition to the main 
source for this chapter – the Nurture case. The concluding chapter in the dissertation will 
provide a recapitulation of the dissertation, recommendations concerning methods in which to 
create legal certainty regarding trade in personal gamete donor information and a 
recommendation concerning areas for further research. 
 
1.7 Structure of dissertation 
 Chapter 2: Gamete Donor Selection: an overview of parental motivations and 
experiences 
This chapter will discuss the various studies that were undertaken to illustrate the 
importance of having access to gamete donor information in general. It will also focus 
on how this aspect enhances the prospective parents’ autonomy in decision-making. 
 Chapter 3: A comparative legal study concerning the provision of donor information 
The USA, UK and Canada will be used in a comparative study as these countries’ 
legal systems share the same basic values with South Africa’s legal system.  
 Chapter 4: An analysis of South African law: can South Africa permit the trade in 
personal gamete donor information? 
This chapter will focus primarily on the various papers filed in the Nurture case – the 
leading source in the chapter – and existing legislation. The arguments in the Nurture 
case and the unpacking thereof are essential to the legal analysis of the topic at hand.  
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 Chapter 5: Conclusion  
This chapter will provide a summary of the dissertation, recommendations of methods 
that create legal certainty regarding trade in personal gamete donor information in 
South Africa and a recommendation concerning areas for further research. 
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CHAPTER 2 – GAMETE DONOR SELECTION: AN OVERVIEW OF PARENTAL 
MOTIVATIONS AND EXPERIENCES 
2.1 Introduction  
What if she’s really ugly! You know it’s the things that you think about. Ridiculous really, 
but (. . .) you do worry.
17
 
the donor might look strange, the donor might have a beaked nose or, something odd (. . .) I 
didn’t imagine the donor could be pretty or nice. (. . .) When I heard she was short, she had to 
be dwarf and I just magnified anxiety about it; the fact that I didn’t know.18 
These are just a couple of the many thoughts that plague some prospective parents during the 
donor-selection process. These thoughts, however, reflect the anxiety that some people 
experience as a result of not having adequate donor information. In this chapter, I discuss the 
following questions: What are the psychological effects of infertility? How important (or not) 
is the process of gamete donor selection to prospective parents? What are prospective 
parents’ donor preferences? Why do prospective parents choose gametes the way they do? Is 
access to Additional Information important? If so, should South African gamete banks make 
the option of accessing Additional Information available to prospective parents? 
 
2.2 Infertility and its psychological effects 
Human reproduction is a social and biological drive.
19
 People have a general expectation of 
parenthood which is often encouraged by social institutions
20
 such as culture.
21
 While couples 
generally have a deep desire to have children, a 2002 study of 729 participants in Sweden 
found that females especially regard biological motherhood (either genetic or gestational) as 
extremely important.
22
 The same study found that 78 per cent of female participants and 67 
per cent male participants agreed with the statement that ‘having children is the most 
important thing in life’.23 Seeing that having a child is a key developmental stage in many 
                                                          
17
 SJ Stuart-Smith, JA Smith & EJ Scott ‘To know or not to know? Dilemmas for women receiving unknown 
oocyte donation’ (2012) 27(7) Human Reproduction 2071. 
18
 Ibid. 
19
 AS Svanberg et al ‘Public opinion regarding oocyte donation in Sweden’ (2003) 18(5) Human Reproduction 
1112.  
20
 Ibid.  
21
 Rodrigues expert opinion 1, 9 May 2013, filed in AB v Minister of Social Development 2017 (3) SA 570 (CC), 
Constitutional Court record pp 852 – 869 para 7. 
22
 Svanberg (note 19 above) 1107.  
23
 Svanberg (note 19 above) 1107. 
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people’s lives,24 it is no wonder then that receiving news of infertility can take people 
unawares, causing them to suffer a range of negative emotions such as depression, stress and 
worthlessness.
25
 In fact, the ill-effects of infertility tend to infiltrate all aspects of a woman’s 
life, whereas men tend to compartmentalise their infertility.
26
 Furthermore, infertile persons 
often experience ‘painful social and psychological consequences’,27 such as feelings of 
isolation and marginalisation.
28
 This may stem from the fact that those near and dear to them 
often cannot completely comprehend the reality and impact of their infertility.
29
 Thus, with 
the use of in-vitro fertilisation (IVF), ‘the transition to parenthood takes place in the context 
of complex losses that derive from their infertility’.30  
 
2.3 The importance of the process of gamete donor selection to prospective parents 
The decision to have a child amounts to an ‘intensely personal decision, at the core of most 
people’s life plans’.31 Equally, people attach great personal importance to the selection of a 
gamete donor
32
 because it is a process that is so emotionally charged.
33
 Clinical experience 
indicates that the selection of gamete donors overlaps greatly with the selection of a life 
partner.
34 Furthermore, this great personal importance is reflected in the significant time, 
thought and mental effort that prospective parents expend when selecting a gamete donor.
35
 
This can be observed in the careful consideration, study and comparison of their options 
when browsing through online databases containing donor profiles.
36
 By playing an active 
role in the process of screening and selecting their donors, prospective parents are able to 
                                                          
24
 IS Rodino, PJ Burton and KA Sanders ‘Mating by proxy: a novel perspective to donor conception’ (2011) 
96(4) Fertility Sterility 998. 
25
 Svanberg (note 19 above) 1110. 
26
 Rodrigues expert opinion 1 (note 21 above) para 9. 
27
 LF Mabasa ‘The psychological impact of infertility on African women and their families’ (D. Phil. thesis, 
University of South Africa, 2009) 2. 
28
 Rodrigues expert opinion 1 (note 21 above) para 10. 
29
 Rodrigues expert opinion 1 (note 21 above) para 10. 
30
 L Cudmore ‘Becoming parents in the context of loss’ (2005) 20(3) Sexual and Relationship Therapy 300. 
31
 Rodrigues expert opinion 1 (note 21 above) para 14. 
32
 Rodrigues expert opinion 1 (note 21 above) para 14. 
33
 S Brown ‘Genetic Aspects of Donor Selection’ in MV Sauer (ed) Principles of Oocyte and Embryo Donation 
(2013) 73, 74. 
34
 Rodrigues expert opinion 1 (note 21 above) para 14; DM Zeifman & JE Ma ‘Experimental examination of 
women’s selection criteria for sperm donors versus life partners’ (2013) 20(2) Personal Relationships 13. 
35
 Rodrigues expert opinion 1 (note 21 above) para 16; L Frith, N Sawyer & W Kramer ‘Forming a family with 
sperm donation: a survey of 244 non-biological parents’ (2012) 24(7) Reproductive BioMedicine Online 716. 
36
 Rodrigues expert opinion 1 (note 21 above) para 16. 
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somewhat alleviate their stress.
37
 Donor egg recipients in particular view the donor screening 
and selection process as a means to take control over their destinies and ‘experience some 
sort of maternal sovereignty’.38  
 
2.4 Gamete recipient preferences and search criteria 
A wealthy merchant and his wife sought treatment for infertility with Dr. William Pancoast. 
When azoospermia was diagnosed, Dr. Pancoast asked the most attractive medical student in 
his class to serve as a sperm donor and later inseminated the wife. The donor was selected by 
the medical team with no input from the couple, and the wife was inseminated with donor 
sperm without the knowledge or consent of either her or her husband. The husband was later 
informed of the insemination, but neither the wife nor the resulting child was told of the use 
of donor gametes.
39
 
Over a century later, assisted reproduction hardly bears any resemblance to this scenario.
40
 
However, within a formal context, sperm donation banks preselect candidates on the basis 
that such candidates will eventually be successful donors.
41
 Furthermore, such agencies and 
banks advise and guide donors as to the type of content that should be put into their profiles, 
so as to make them more ‘saleable’.42 As such, prospective parents are often aware of the fact 
that donors, gamete banks and agencies have a vested interest in donor profiles.
43
 In a 2012 
study involving 22 egg recipients in the United States of America (USA), participants felt 
that profiles were sometimes ‘unreliable’ as they were deliberately made to simply ‘look 
good’ and get selected by the respective clinic and recipients.44 It is argued that the process of 
gamete banks and agencies preselecting donors reflects bias in the possibility set of 
prospective parents.
45
 It is also argued that for the sake of prospective parents, donor profiles 
                                                          
37
 H Flores et al. ‘Beauty, Brains or Health: Trends in Ovum Recipient Preferences’ (2014) 23(10) J of Women’s 
Health p831. 
38
 Ibid.  
39
 JT Woodward ‘Third-party reproduction in the Internet Age: the new patient-centered landscape’ (2015) 
104(3) Fertility and Sterility 525. 
40
 Ibid. 
41
 S Whyte & B Torgler ‘Determinants of online sperm donor success: how women choose’ (2016) 23(8) 
Applied Economics Letters 592. 
42
 Ibid.  
43
 LR Rubin et al. ‘Once you’re choosing, nobody’s perfect: is more information necessarily better in oocyte 
donor selection?’ (2015) 30(3) Reproductive BioMedicine Online 315. 
44
 Ibid. 
45
 Whyte & Torgler (note 41 above) 593. 
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should provide ‘a fairly accurate image of the donor so that they are reassured about the 
origin of the material and are able to handle the transaction more easily’.46 
In contrast, the informal and unregulated online market – born from a global shortage of 
gamete donors
47
 – allows more recipient-donor communication.48 Therefore, this allows for a 
true reflection of what characteristics prospective parents find most appealing.
49
 Seeing that 
the internet has served as a conduit for gamete donation,
50
 prospective parents have access to 
a wide spectrum of information which even allows them to find their own donors without 
consulting a gamete bank or agency.
51
 However, how exactly do prospective parents choose 
their donors? 
Evidence suggests that people often choose their mates in terms of assortative mating and 
homogamy, that is, they often select mates who share common characteristics as them with 
regard to physical characteristics, psychological characteristics, socio-economic status and so 
forth.
52
 Despite the advent of the internet, which offers a greater variety of mates by 
superseding geographical and social proximity barriers, the feature of choosing mates in 
terms of homogamy is as common as when picking a mate in the same geographical and 
social proximity.
53
 Surprisingly, within the context of selecting a sperm donor, women 
generally display homogamy with regard to their own characteristics as well as that of their 
partners.
54
 
Although there is great diversity in what prospective parents prioritise as important donor 
characteristics,
55
 there are grounds of similarity as well.
56
 While past trends indicate that 
more than half of the couples chose donors with an emphasis placed on physical resemblance, 
ethnicity and common genetic heritage,
57
 prospective parents’ donor choices are increasingly 
motivated by characteristics that would be of benefit to the donor-conceived child’s mental 
                                                          
46
 G Pennings ‘The right to choose your donor: a step towards commercialization or a step towards empowering 
the patient?’ (2000) 15(3) Human Reproduction 514. 
47
 Whyte & Torgler (note 41 above) 592. 
48
 Whyte & Torgler (note 41 above) 593. 
49
 Whyte & Torgler (note 41 above) 593. 
50
 Whyte & Torgler (note 41 above) 592. 
51
 Woodward (note 39 above) 525. 
52
 S Whyte & B Torgler ‘Assortative mating in the online market for sperm donation’ (2016) 18(3) J of 
Bioeconomics 170. 
53
 Ibid 172. 
54
 Ibid 184. These characteristics especially relate to ethnicity, personality traits and agreeableness (such as 
being older or a lesbian). 
55
 Pennings (note 46 above) 509; CT Drewes Anonymous Sperm Donor Preferences of Non-Genetic Mothers 
(Master of Social Work, Smith College School for Social Work; Northampton, MA, 2009) p72. 
56
 Rodrigues expert opinion 1 (note 21 above) para 18. 
57
 Flores et al. (note 37 above) 832; Zeifman & Ma (note 34 above) 3. 
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and physical health (‘good genes’), such as athleticism and intellect.58 In fact, in a 2009 
survey of 244 non-biological parents in the USA, 91,8 per cent of participants revealed that 
they would not have chosen a sperm donor if no health record was available on the particular 
donor.
59
 Additionally, in a 2012 online survey that used 56 potential sperm donors, 
personality characteristics (such as being systematic, introverted and so forth) outweighed 
physical characteristics (such as height, weight and so forth) in donors.
60
 Therefore, it can be 
said that prospective parents tend to choose donor characteristics that follow ‘general societal 
norms and perceptions of success’.61 Where, then, does this leave the importance of physical 
similarity, ethnicity and common genetic heritage? 
The aforesaid studies do not imply that physical similarity, ethnicity and common genetic 
heritage have decreased in importance. It simply means that many prospective parents are 
now also placing importance on donor personality traits and characteristics that would be of 
‘benefit’ to the donor-conceived child (health being the most favoured characteristic).62 In a 
2012 study involving 22 egg recipients in the USA, most participants in the survey shared 
two main goals: first, to have a healthy child, and secondly, to have their donor-conceived 
child ‘pass’ as genetically linked to them.63 Matching the donor’s physical features to the 
non-genetic parent allows for the constructive genetic link between the non-genetic parent 
and the donor-conceived child, thereby masking the obviousness of the donation
64
 and 
ensuring some sort ‘genetic continuity’.65 Consequently, medical information and specific 
physical donor characteristics are still of particular importance to prospective parents.
66
 
When evaluating donor characteristics, prospective parents are also curious about donors’ 
reasons for donating their gametes.
67
 Many prospective parents often bring up the question of 
donor motivation in the hope that it stems from altruism (financial motivation is viewed as 
emotive).
68
 Consequently, altruistic motives are appreciated, while financial incentive 
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removes the donor as an option.
69
 Furthermore, ‘…recipients regard this information as 
particularly important for their offspring’s view of self and that a donor who has been 
altruistic enables the recipient to make the narrative of the birth story more sensitive to the 
perceived needs of their donor-conceived child’.70 
Ultimately, it can be seen that irrespective of whether it is a formal or informal context, many 
prospective parents display homogamy in their choices of gamete donors. In addition to a 
donor’s physical characteristics, genes that would be of benefit to the donor-conceived child 
as well as reasons for the donation are of importance to prospective parents. 
 
2.5 Is access to additional information important? 
Not enough attention has been given to the type and quantity of donor information that is 
provided to prospective parents.
71
 Within the South African context, this aspect has been 
thoroughly neglected up until recently. Over the last two decades, there have been on-going 
global demands for more donor information, as well as for further choice during donor 
selection.
72 In fact, the global demand for donor information has grown to the point where 
identity-release
73
 gamete donors have become increasingly popular.
74
 Consequently, this has 
led numerous international gamete banks and agencies to provide extensive personal donor 
information such as photographs, audio recordings and video recordings.
75
 In the USA, there 
are many models of donor information that are made available to prospective parents (which 
have been available for over two decades already).
76
 It ranges from the most basic 
information (such as medical history and a description of physical appearance) to 
substantively detailed (such as adult photographs and audio clips).
77
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A 2009 online survey involving 244 lesbian sperm recipients in the USA demonstrates that 
the most vital criterion in the selection of a sperm bank was the amount of donor information 
the bank provided.
78
 This suggests that during the selection process, prospective parents want 
detailed donor information so as to make an informed decision.
79
 In this way, prospective 
parents may experience greater autonomy.
80
 In the 2012 study involving 22 egg recipients in 
the USA, some participants felt that access to substantively detailed donor information 
allowed them to be informed and have the process under control: ‘No one likes to buy things 
without seeing what something looks like. So this is like a huge purchase [laughs]. . .’81  
Some participants found ‘signs’ within the information which they interpreted to be 
indicators that they were choosing the correct donor. Others built narratives and fantasies 
about donors, by ‘reading in between the lines’ of the information provided: 
 and of course [we wanted to know] if she had kids herself. Like that almost like made us feel 
better if she had a kid. . .She’s like a young girl, like why she’s doing it? What’s her motive? 
But if she could have kids herself and just wants to give some of her own eggs we felt like, 
oh, this is like a really good person. And I wanted somebody who had good traits also. You 
know, a good person.
82
 [Own emphasis] 
In a 2011 study using 11 egg recipients in the UK, some recipients experienced a fear of the 
unknown due to a lack of adequate donor information.
83
 These recipients then sought IVF 
treatment in the USA, were it is possible to access more comprehensive donor information.
84
 
Some recipients simply sought enough information for them to feel that they trust their 
donors: ‘I always remember someone saying that they felt their babies were going to come 
out with blue flashing lights saying, ‘I’m different, I’m from donated eggs’. (. . .). I never had 
any of those worries (. . ..), because I had the security of knowing what their donor is like’.85 
While a great amount of information allowed for increased trust in the donor and a decrease 
in anxiety, others without such access simply imagined the donor in a polarised fashion.
86
 
This did not necessarily bring relief, as once again, there was a fear of the unknown and some 
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recipients imagined the worst possible outcomes for their donor-conceived child.
87
 
Interestingly, the 2011 study using 11 egg recipients in the UK refers to clinical experience 
that points to many recipient couples experiencing negative fantasies about the donor 
(especially in the earlier stage of the pregnancy) when they were provided with little to no 
donor information.
88
 
All this being said, gamete recipients may also view access to a great amount of donor 
information in a negative light. Despite there being a generally positive attitude towards the 
great amount of information available, more than half of the participants in the 2012 study 
involving 22 egg recipients in the USA expressed at least one instance where such 
information undermined the process of choosing a donor.
89
 Many participants were in search 
of the ‘perfect’ donor, but after having had access to the donor information, many soon 
realised that there was in fact no ‘perfect’ donor.90 This meant that participants had to choose 
from a range of ‘imperfect’ donors, leaving some with a feeling of dissatisfaction or having 
settled for less.
91
 Overall, some participants felt overwhelmed by all the donor information 
that was provided to them, and surprisingly wished that they had less information.
92
 
Providing prospective parents with sufficient information to make an autonomous decision is 
difficult without causing the aforesaid problems.
93
 In fact, the question of how much donor 
information should be provided to prospective parents is a highly contested debate within the 
field of reproduction.
94
 The debate is fuelled by the fact that there is little empirical research 
in this area to provide adequate guidance.
95
 Consequently, many recipients find the decision-
making process burdensome.
96
 Initially, some felt that it was rational to make use of all the 
information they were provided in order to make an informed decision.
97
 Yet, in a sense, they 
felt obliged to make use of all the donor information since it was available to them.
98
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While many international fertility centres provide detailed donor profiles such as adult 
photographs (sometimes including those of the donor’s own children and other family 
members), some fertility centres aim to keep donor anonymity through the sole provision of 
childhood photographs. The danger is that, the more presumably non-identifying information 
a donor provides, the more the donor’s anonymity is compromised.99 A motivated 
prospective parent willing to invest the time and effort
100
 may be able to use age progression 
software to develop an adult image using the childhood photograph.
101
 In fact, there are 
websites which provide guidance as to which search tools should be used to identify the 
donor, depending on what information is available.
102
 Ultimately, a ‘for-and-against extra 
donor information’ argument can be made. The argument for extra information is that it 
allows prospective parents to make a truly informed (autonomous) decision about the donor 
they want.
103
 On the other hand, the argument against extra donor information is that it is 
unlikely that any amount or type of donor information would lead to any understanding of the 
donor as a person, and so such information may not hold much significance.
104
 
 
2.6 To have or not to have additional donor information, that is the question 
Should South African gamete banks provide prospective parents the option to access 
Additional Information? As it can be observed in the previous subsection, there are various 
subjective pros and cons to having Additional Information. The only two objective factors 
that can be extracted from the various pros and cons are the possible use of age progression 
software to determine a donor’s possible adult face (and hence identity), and the other is a 
core biomedical
105
 principle related to decision-making – autonomy. How do these two 
arguments measure against each other? 
First, the use of age progression software is not an exact science.
106
 While some software 
produces better results than others, thus far, there has not been a single technology that can 
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determine a future image of a person with complete accuracy. Additionally, it becomes 
increasingly difficult to generate an accurate image with the use of childhood photographs: 
‘“Aging photos of very young children from a single photo is considered the most difficult of 
all scenarios…,”…Part of that challenge is using candid photographs, not posed portraits, to 
generate a future likeness.’107 Depending upon the effectiveness of the software used, there 
would be myriad of factors that one would have to consider before a fairly accurate image is 
generated (assuming the donor does not have any changes to his/her physical features,
108
 
either intentionally through plastic surgery or by accident) as aging is influenced by various 
factors.
109
 The risk of donor anonymity being compromised in this manner does exist, 
however, it is negligible.  
Interestingly enough, donor anonymity is becoming increasingly compromised in any event, 
particularly with the use of genetic testing.
110
 Genetic testing, unlike age progression 
technology, is clearly an exact science: ‘In 2005, a 15-year-old boy tracked down his father 
after taking a Y chromosome test with a commercial ancestry company. His father was not in 
the database but was identified through a match with another man sharing the same rare 
surname’.111 The argument, therefore, that age progression technology compromises donor 
anonymity is irrelevant in the face of an exact science such as genetic testing, which requires 
absolutely no donor information to determine donor identity. How does this ‘risk’ compare 
with autonomy? 
Autonomy refers to the concept of ‘self-rule’, where a person – after being given all the 
relevant information about a particular situation – can make a truly informed decision.112 
Respecting a person’s autonomy includes obtaining informed consent before any medical 
examination, treatment or surgery.
113
 Informed consent is not only an ethical requirement, but 
is also a legal requirement.
114
 It refers to eliciting a person’s permission to proceed with a 
certain medical procedure, after such person has deliberated over all the risks and benefits of 
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each and every option available to him/her.
115
 Such deliberation is derived from one of 
informed consent’s threshold elements - disclosure.116  
Applied to the question at hand, I submit that counter-arguments to the provision of 
Additional Information, particularly the argument of causing undue stress and imposing 
burdens (both concepts being subjective perceptions) upon prospective parents, does not hold 
water. Considering that stress is a normal occurrence in life, it is not a legally or ethically 
relevant consideration. In fact, being stressed about such a situation can actually be seen in a 
positive light. Prospective parents should feel stressed, albeit not debilitated, by a decision 
that has a presumably life-long consequence. Surely the value of autonomy triumphs over the 
possible harm of being ignorant in matters of such a serious nature. Furthermore, the 
negligible risk of having an extremely keen gamete recipient trying to conjure up an adult 
image of his/her child’s donor through age progression, cannot compare to a gamete 
recipient’s need to make a fully informed choice with regard to their future child. Therefore, 
in order to promote autonomy, South African gamete banks and agencies should ideally go 
beyond their legal duty of providing Required Information by providing prospective parents 
the option of accessing Additional Information. While there is a possibility that some 
prospective parents may not want Additional Information, the option of accessing such 
information should necessarily exist for those who do wish to have such information. 
 
2.7 Conclusion 
Procreating is a primal drive in most – if not all – species, with humans as no exception. As 
having children constitutes a core part of most people’s lives, news of infertility can cause 
devastating psychological effects in people. Since many infertile people choose gamete 
donation as a means to fulfilling their parenthood, the process of carefully selecting a gamete 
donor is extremely important in somewhat alleviating the negative psychological effects of 
infertility, as well as helping infertile persons feel that they have retained some control in an 
area of life that would have otherwise felt like a hopeless loss.  
Although there is great diversity in what prospective parents prioritise as important donor 
characteristics, there are grounds of similarity as well. While past trends indicated that more 
than half of infertile couples chose donors mainly based on physical similarity, ethnicity and 
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common genetic heritage, recent studies have shown that prospective parents are increasingly 
choosing donors based on ‘good genes’ and the benefits it will confer to the donor-conceived 
child. Additionally, donors are looked upon favourably when they choose to donate for 
altruistic reasons as opposed to financial reasons. 
For some prospective parents, donor selection and Additional Information may be 
inextricably linked as it enhances their autonomy and alleviates fear of the unknown. For 
others, Additional Information may have an adverse effect and hamper the selection process 
by causing undue stress and burdens upon them. Furthermore, there is a slight risk that 
Additional Information may compromise donor anonymity in cases where revealing the 
donor’s identity is prohibited either by the donor’s personal choice or law. Ultimately, 
satisfying all stakeholders may prove to be difficult, if not impossible. The best possible 
solution, therefore, is focusing on the only viable and objective argument – autonomy.  
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CHAPTER 3 – A COMPARATIVE LEGAL STUDY CONCERNING THE PROVISION 
OF DONOR INFORMATION 
3.1 Introduction 
In the previous chapter, the importance of Additional Information to prospective parents was 
highlighted and argued for. This chapter focuses on the analysis of practices concerning the 
provision in gamete donor information in three jurisdictions: the USA, UK and Canada. 
These three jurisdictions were chosen because, (1) their legal systems share the same basic 
values with South Africa’s legal system; (2) their law is easily accessible online; (3) their law 
is in English; and (4) there are relatively high numbers of academic publications analysing 
the regulation of the fertility industries in these countries. It is worth noting that these three 
countries, like every other country, do not legally regulate the trade in gamete donor 
information per se. Had the Nurture case been adjudicated upon, South Africa would have 
been the first country in the world to have judicially addressed this matter. In any event, it is 
worth studying how developed countries such as the USA, UK and Canada deal with the 
issue of provision and trade in donor information, and how gamete agencies and banks in 
these countries also function in relation to this particular lack of regulation. Furthermore, it 
must be noted that unlike South Africa, the USA, UK and Canada do not have legislation 
mandating specific information to be recorded and disclosed to prospective parents. In 
Chapter 1, this type of specific information within a South African context was referred to as 
Required Information (as per the Nurture case). This South African legal requirement 
allowed Nurture to distinguish between Required Information and Additional Information. 
However, with regard to the USA, UK and Canada, no such legal distinction can be made 
because the laws of these jurisdictions do not create a numerus clausus of information that is 
required as South Africa does. Lastly, as the term ‘Additional Information’ has a South 
African-specific meaning (discussed in Chapter 1), the term ‘detailed/extended donor 
information/profile’ will be used to describe donor information/profiles in the comparator 
countries that have a roughly equivalent content to Additional Information. 
Before commencing the comparative study, it must be noted that gamete agencies and banks 
often use the terms ‘identity-release’, ‘open-identity’, ‘identity-disclosure’ and ‘non-
anonymous’ in order to refer to donors that are anonymous but agree to have their 
identifying/contact information (such as their full name, last known address, telephone 
number etc) released to donor-conceived offspring, on condition that these offspring are 18 
years and above (ie adults) and have specifically requested such information. In other words, 
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these donors are anonymous until their identities are revealed upon their adult donor-
conceived children’s requests. For the purpose of this dissertation, such donors will 
consistently be referred to as ‘identity-release’ donors. 
 
3.2 UK 
The UK is the first country to have passed legislation that extensively regulates reproductive 
technology,
117
 viz the Human Fertilisation and Embryology Act 1990 (‘the HFE Act of 
1990’).118 Prior to the HFE Act of 1990, it was common practice for donor anonymity to be 
enforced.
119
 It came as no wonder then that the HFE Act of 1990 barred prospective parents 
from receiving identifying information about gamete donors, albeit allowing donor-conceived 
offspring the right to access non-identifying donor information, once they were 18 years of 
age.
120
 Donor anonymity, however, had caused much dissatisfaction in the ensuing years 
which led to debates, a court case
121
 and lobbying from non-governmental organisations.
122
 
Consequently, in early 2000 after public consultation, the HFE Act of 1990 underwent review 
which resulted in new legislation: the Human Fertilisation and Embryology Act 2008 (‘the 
HFE Act’).123 Like South Africa, the UK has two types of gamete donors: anonymous and 
known (known donors are clearly known to the recipient or prospective parents eg family 
members or friends). The HFE Act provides that donor-conceived offspring, who were 
conceived from gametes that were donated after 1 April 2005, can request non-identifying 
donor information
124
 from the Human Fertilisation and Embryology Authority (‘HFEA’) after 
the age of 16.
125
 Furthermore, the HFEA allows donor-conceived offspring access to 
identifying information pertaining to their donors from the HFEA after the age of 18.
126
 
Essentially, this means that as of 1 April 2005, all donors are identity-release donors, as their 
identities can be legally accessed by their adult donor-conceived offspring.  
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With regard to prospective parents, nothing much has changed. While prospective parents 
may request non-identifying donor information from the HFEA after their donor-conceived 
child is born (note that this is not even a statutory right), they are not legally entitled to access 
non-identifying donor information for the purpose of choosing gametes. In terms of the HFE 
Act, it is my understanding and interpretation of section 33A(2)(h)
127
 read together with 
section 33B,
128
 that if a gamete donor has consented, his/her non-identifying information can 
be disclosed. Provision of detailed donor information, therefore, is left to the discretion of 
gamete agencies and banks as they are not legally prohibited from doing so.
129
 In a 2016 UK 
journal article that analysed whether prohibiting or mandating donor anonymity protects the 
interests of donor-conceived offspring, it was claimed that many gamete agencies and banks 
in the UK collect a significant amount of non-identifying donor information, though not 
legally obliged, to help prospective parents in their choice of gamete donors.
130
  
In order to determine the amount of donor information UK gamete agencies and banks 
choose to provide prospective parents, I randomly selected and searched the following seven 
UK gamete donor websites: New Life Egg Donation Agency, Atrui Egg Donation, Nurture 
UK, London Sperm Bank Donors, London Egg Bank Donors, Fairfax Cryobank (UK branch) 
and Complete Fertility. A quick browse of the websites reveals the following: 
 New Life Egg Donation Agency: claims to offer ‘personalized one-on-one matching’ 
in addition to offering detailed donor profiles containing non-identifying information 
(there is no ‘basic profile’ with the option of purchasing extra information).131 All 
donors are identity-release donors (donor-conceived children can request identifying 
donor information as per the HFEA). While the agency states that donors have 
detailed profiles, these profiles are not provided on an online database for parents to 
browse through and select. Prospective parents must advertise the requirements they 
want their donors to possess with regard to ‘physical characteristics as well as any 
extra requirements you may have regarding the donor’s blood group, education, 
interests, talents and abilities’132 ie the agency best matches the prospective parents to 
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the donors in accordance to the requirements the prospective parents have asked for. 
Thus, these detailed profiles are essentially for the agency’s use for the purpose of 
matching prospective parents to donors. Prospective parents do not pay for extra 
information as it is not applicable in this scenario. 
 Atrui Egg Donation: unlike the New Life Egg Donation Agency, this agency claims to 
offer prospective parents the most amount of non-identifying donor information than 
any other gamete agency or bank in the UK.
133
 It appears that this agency’s business 
is hinged on providing the most amount of non-identifying donor information ie it 
does not provide a basic donor profile first, and then ask for additional payment for 
access to the extra information. This, it claims, sets it apart from its competitors which 
the agency is clearly proud of. [See screenshots below] 
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 Nurture UK: this is the UK branch of Nurture. As is the case with the South African 
branch, the UK branch offers ‘full information about prospective donors, including 
personality and character information, family history going back two generations, 
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education history, medical information, etc’.134 There is no indication that a basic 
donor profile is first given with the option of accessing extra information at a fee – the 
extra information is merely provided without extra payment. 
 London Sperm Bank Donors: this bank provides a basic biographical description of its 
donors (such as ethnicity, ethnicity of parents, highest qualification attained, staff 
impression, a scant personality description etc) but does not offer the option of 
purchasing detailed donor information.
135
 At most, it offers a category of donors that 
have a pen sketch and an extended profile available, but this information must be 
requested from the HFEA and not the bank itself.  
 London Egg Bank Donors: this is the partner bank of the London Sperm Bank 
Donors. Like the aforementioned bank, a basic biographical description of its donors 
exists.
136
 If a pen sketch of the donor exists, it must be requested from the HFEA. 
 Fairfax Cryobank (UK branch): this USA-based bank freely offers prospective parents 
information such as a summary profile, medical profile, staff impression, donor essay 
and an audio clip of the donor.
137
 If prospective parents want extra donor information, 
they would have to purchase an information package option. [see screenshot below] 
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 Complete Fertility: prospective parents ‘can select donors based on their physical 
characteristics and their employment, education and hobbies’.138 There is no option of 
purchasing any information in addition to the aforesaid information. 
As can be seen above, gamete donor agencies and banks in the UK do not behave uniformly 
with regard to the provision of detailed information. While there are some gamete agencies 
and banks that choose to exclusively provide basic biographical information, there are more 
agencies and banks that do choose to provide detailed information, albeit at varying amounts 
of information. In fact, as was already discussed, Altrui Egg Donation’s core business is 
focussed on matching prospective parents with donors based on an extensive amount of non-
identifying donor information. Of these agencies and banks that do provide detailed 
information, most provide it at no extra cost (Fairfax Cryobank being the exception). While 
Fairfax Cryobank seems to be the only bank trading detailed information (from the other 
gamete agencies and banks that were selected), it is still indicative of the fact that detailed 
information can be traded in a system where donor anonymity is protected. The UK and 
South Africa are in a similar position with regard to the prohibition of the trade in gametes
139
 
and the protection of donor anonymity (apart from the instance where UK donors have their 
identities released to adult donor-conceived offspring). Yet many gamete agencies and banks 
in the UK still choose to provide detailed non-identifying donor information to prospective 
parents. This contrasts with South African gamete agencies and banks, where thus far, the 
vast majority of gamete agencies and banks provide a scant amount of Additional 
Information. 
 
3.3 Canada 
As is the case in South Africa, gamete donation in Canada can either be anonymous or 
known.
140
 In Canada, assisted human reproduction is regulated by the Assisted Human 
Reproduction Act S.C. 2004, c. 2 (‘the AHRA’). The AHRA was a comprehensive piece of 
legislation that was enacted by the federal government in 2004.
141
 The AHRA, inter alia, had 
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created a complex system for the processing
142
 of both identifying and non-identifying 
information of stakeholders such as donors, prospective parents using artificial reproductive 
technologies (‘ARTs’) and donor-conceived offspring.143 It had protected donor anonymity 
by stipulating that donor-conceived offspring could only be provided certain non-identifying 
information about their donors, and identifying donor information was to only be disclosed 
upon the consent of the donor.
144
 Many of the details concerning the processing of 
stakeholders’ information (both identifying and non-identifying) were to be encapsulated 
within regulations. Of particular importance is the fact that the regulations were meant to, 
inter alia, stipulate that physicians had to collect identifying and non-identifying donor 
information, but only disclose non-identifying donor information to prospective parents for 
the purpose of choosing a donor. Although it is not certain, it is likely that this information 
would have almost mirrored Required Information ie height, weight, eye colour, medical 
history etc.
145
 These regulations, however, never had the chance to be drafted.
146
  
Shortly following its enactment, the AHRA found itself challenged by the Attorney General 
of Quebec (‘AGQ’).147 The AGQ argued that many of the health-related provisions in the 
AHRA were ultra vires Parliament’s legislative authority,148 and rather belonged in the realm 
of provincial legislative authority.
149
 The AGQ succeeded, and though the case was appealed 
at the Supreme Court of Canada, the Court held that the majority of the provisions in the 
AHRA belonged to the legislative authority of the provinces as they were health-related 
provisions.
150
 However, the sections that did survive in their entireties include the: short title 
(section 1), principles (section 2), prohibited activities (sections 5-9),
151
 and offences 
(sections 60-64).
152
  Consequently, many of these provisions were soon repealed,
153
 which 
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‘effectively removed the federal law mandating donor anonymity, leaving only the provincial 
and territorial privacy statutes to fulfil this function’.154  
To date, however, most of the provincial legislatures have neglected to regulate this area, 
particularly with regard to donor anonymity and information.
155
 Of the few provincial 
legislatures that have passed legislation, the focus of the legislation relates to the funding of 
IVF.
156
 As such, there is now regulatory uncertainty within the area of assisted human 
reproduction.
157
 Despite this regulatory uncertainty, however, it seems that many Canadian 
gamete agencies and banks have not veered away from the previous system of donor 
anonymity. As Canadian gamete donation currently operates in an environment of great legal 
uncertainty, the Canadian fertility industry has largely created its own certainty by simply 
operating in a system that would help it avoid judicial scrutiny – anonymity.158 In other 
words, for there to be commercial certainty, the industry had to create its own ‘system’ in the 
absence of substantial legal regulation.
159
 ‘“Buyers want to buy, donors want to sell, banks 
want to market,” and doctors want to make money, help vulnerable patients, and/or advance 
science’.160 Donor anonymity, then, serves multiple interests in this regard (apart, perhaps, 
from donor-conceived offspring): 
Donors have a vested interest in avoiding claims of parentage or support that exceed their 
contractual intention to donate. Intending parents suffering from infertility may want to 
conceal the circumstances of their children's birth and avoid claims of parentage by third 
party donors. As for banks, agencies, and medical professionals, their main consideration vis-
a-vis the law may be simply to avoid entanglements in unpredictable lawsuits.
161
 
For the purpose of using Canada as a comparator, however, it can be accepted that despite the 
lack of a comprehensive regulatory system, Canada – like South Africa – practices donor 
anonymity. In light of this statement, an observation of how Canadian gamete agencies and 
banks operate with regard to the provision of donor information must be made. A quick 
Google search allowed me to randomly pick four websites of Canadian gamete 
agencies/banks: Xytex, ReproMed, Donor Egg Bank USA, and Little Miracles. 
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 Xytex: offers both anonymous and identity-release sperm donors.162 It freely offers 
basic information and a very limited amount of detailed information. For extensive 
detailed information, prospective parents can purchase what Xytex calls ‘enhanced 
donor profiles’, either at $75 for a 90-day access to a single profile, or $225 for a 90-
day access to all ‘enhanced’ donor profiles. Enhanced donor profiles include more 
information such as child and adult photographs, donor essay, personality test etc. 
Photographs can be viewed online, but there is an option of purchasing hardcopy 
photographs.  
 ReproMed (The Toronto Institute for Reproductive Medicine): offers both anonymous 
and identity-release sperm donors. Basic donor information (similar to Required 
Information) can be accessed free of charge, but access to all extended donor profiles 
(for a limited period of time) is offered at a fee.
163
 Extended donor profiles may 
contain some or all of the following donor information: temperament report, essays, 
audio clips, donor likeness photographs, and staff impression. [See screenshot below] 
 
 
                                                          
162
 https://www.xytex.com/patient-information/donor-options/, accessed 2 November 2017. 
163
 https://www.repromed.ca/extended_donor_profiles, accessed 2 November 2017. 
31 
 
 Donor Egg Bank USA: although this bank is essentially a network of egg donation 
programs in the USA,
164
 some fertility clinics in Canada, such as Olive Fertility 
Centre,
165
 import eggs from it for their Canadian clients. Donor Egg Bank USA offers 
both anonymous donors (yet adult photographs of these donors are provided) and 
identity-release donors. They do not charge a fee for registering for an account on 
their website, or for viewing donor profiles.
166
 Donor profiles seem to contain varying 
amounts of donor information. Prospective parents may only seek treatment in 
California, New York or Canada.  
 Little Miracles: claims to be the only egg donation agency in Canada.167 It offers 
‘comprehensive’ donor information, although this information is not available for 
browsing on the website. Although it does not charge an additional fee for these 
detailed profiles, access to the profiles can only be gained if a prospective parent first 
registers and fills out a questionnaire.
168
 This questionnaire is then reviewed by a co-
ordinator, who then contacts the prospective parent to learn more about the 
prospective parent and his/her specific requirements.  
It must be noted that there are many more USA gamete banks, like Donor Egg Bank USA, 
that export their gametes to Canada (the reason for this will be explained at the end of the 
USA section below). Furthermore, there are not as many gamete agencies and banks in 
Canada as there are in the USA. As such, there was an overlap in the Google search results, 
with a narrow range of Canadian agencies/banks to choose from. Therefore, I refrained from 
discussing more USA gamete banks in this section. 
At this juncture, it is also worth mentioning that, like South Africa, Canada’s ban on the trade 
in gametes is still in place.
169
 Trade in gametes is strictly prohibited by section 7(1) of the 
AHRA, which states that: ‘No person shall purchase, offer to purchase or advertise for the 
purchase of sperm or ova from a donor or a person acting on behalf of a donor’. In any event, 
it can be seen that despite operating in a system of anonymity, Canadian agencies and banks 
often provide detailed donor information to prospective parents, often at an additional charge. 
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Once again, this contrasts greatly with most South African gamete agencies and banks that 
fail to provide such an option to prospective parents. 
 
3.4 USA 
For thousands of couples in the USA, reproductive technology realises their dream of 
becoming parents.
170
 It is estimated that 62 million women alone in the country suffer from 
infertility, and approximately 7,4 million of these women will utilise reproductive technology 
at some point in their lives.
171
 It is no wonder then that ARTs have turned into a lucrative 
multi-billion dollar industry in the USA,
172
 albeit being a private industry.
173
 In fact, sperm 
donation alone generates annual revenue of 3.3 billion dollars.
174
 For an industry that clearly 
contributes to and impacts the USA economy,
175
 it would naturally be expected that such an 
industry would be heavily regulated. The irony, however, is that the USA fertility industry 
severely lacks comprehensive federal- and state-level regulation: 
Unlike the United Kingdom and Canada, oversight of ART in the United States is not led by a 
dedicated regulatory body. Rather, the industry relies primarily on self-regulation in the form 
of voluntary guidelines issued by two professional associations—the American Society for 
Reproductive Medicine (ASRM) and the Society for Assisted Technology (SART)… Fertility 
clinics in the United States are also subject to state regulation, but few states have chosen 
specifically to regulate this industry and none has created a central oversight body similar to 
the HFEA or ARHC.
176
 [Own emphasis] 
"[w]e have more rules that go into place when you buy a used car than when you buy 
sperm."
177
 
At most, the ASRM recommends that donor information should be recorded and kept 
indefinitely.
178
 Also, with so few states exercising their discretion to regulate gamete agencies 
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and banks,
179
 there is no uniformity ‘as to how, whether, and under what conditions, donors’ 
information is obtained, is checked, and can be released’.180 With regard to gamete 
regulation, there clearly is a stark contrast between the USA and many other Western 
countries (such as the UK, Netherlands, Norway etc)
181
 and arguably even South Africa with 
the NHA and its Regulations. Hence, with little external authority to govern it, the USA 
fertility industry has total control over donor information and how to deal with it.  
It comes with little surprise, therefore, that the USA has not prohibited the practice of donor 
anonymity;
182
 a practice that has endured for over a century.
183
 While the majority of gamete 
donations occur anonymously, like Canada and South Africa, known donations do occur in 
the USA and some gamete agencies and banks also choose to have identity-release donors, 
without being legally mandated to do so.
184
 Washington is the only exception in this regard; 
Washington is the only state whose law, as of 2011, requires gamete donors to be identity-
release donors ie allow their identifying information to be made available to donor-conceived 
offspring who request it after the age of 18.
185
 The proviso, however, is that a gamete donor 
can instruct the fertility clinic to not make their identifying information available to the 
donor-conceived offspring.
186
 It is submitted that this proviso makes the law redundant in 
instances where donors in Washington opt to not have their identifying information released. 
With most of the states operating in a system of donor anonymity, what then makes the USA 
fertility industry such a success? 
The USA proves to be a key player in reproductive tourism – a phenomenon that sees many 
people from across the globe seeking fertility treatment in the USA, rather than in their own 
countries.
187
 While the fact that the industry being unregulated at a national and state level 
may make it easier for the industry to function as it pleases, I suggest that another reason that 
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makes USA gamete agencies and banks a preferential choice for many prospective parents is 
the availability of detailed donor information. In the previous chapter, it was mentioned that 
many prospective parents – from the USA and other countries as well – would prefer having 
detailed donor information. Much of the evidence for this statement was based on studies 
conducted in the USA. Clearly, there seems to be a link between the USA’s gamete agencies’ 
and banks’ popularity and the manner in which they operate as businesses, especially with 
regard to the amount of donor information they generally provide despite practicing donor 
anonymity in most instances. While basic donor information is always provided, detailed 
donor information is provided only as a matter of choice for the gamete agency or bank.
188
 
With freedom for USA gamete agencies and banks to trade in donor information as they 
please, many of these agencies and banks choose to provide detailed donor information, as 
consumer demand has warranted it.
189
 
Upon my Google search, I randomly selected and searched six USA gamete agencies’ and 
banks’ websites for information regarding the provision and trade of donor information. The 
six agencies/banks were: Cryos International, Fairfax Cryobank, Fairfax Egg Bank, Donor 
Egg Bank USA, Seattle Sperm Bank, and The Sperm Bank of California. 
 Cryos International: this bank offers both sperm and eggs.190 Sperm and egg donors 
are either anonymous or identity-release. Egg donors – irrespective of whether they 
are anonymous or identity-release – have detailed profiles with varying amounts of 
donor information. Sperm donors, on the other hand, are available with either a basic 
profile or detailed profile eg prospective parents can choose a non-anonymous donor 
with a basic profile if they wish etc. There is no extra fee for accessing detailed 
profiles. [see screenshots below] 
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 Fairfax Cryobank: this bank offers both anonymous and identity-release donors. The 
Fairfax Cryobank allows prospective parents to browse through summary donor 
profiles, medical history (including that of the donor’s family), childhood 
photographs, donor essays, audio clips etc free of charge.
191
 If prospective parents 
wish to access further detailed non-identifying donor information (such as a personal 
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profile, full audio interview, personality test results etc), they would have to purchase 
a package option to gain such access (the cost depends on the package option the 
prospective parents want to purchase).  
 Fairfax Egg Bank: this bank is a ‘sister’ company to the Fairfax Cryobank. It does not 
require prospective parents to register or pay a fee for viewing donor profiles 
(effectively, anyone can freely browse through the profiles).
192
 Unlike its ‘brother’ 
company, the egg bank does not offer donor information packages for purchase. All 
donors are anonymous – no identity-release donors are offered. It states that it offers: 
…a significant amount of detailed information about each egg donor. In fact, our 
program is one of the few to offer such a vast amount of information on each donor. 
Profiles can be found on the website, including medical and personal history, donor 
essays, audio interviews, and childhood photos. Adulthood photos for all donors are 
also available as a patient of any affiliate clinic once the confidentiality agreement 
has been signed and returned, as a reasonable precaution to preserve their anonymity. 
Many recipients say that this additional information and extensive screening are 
incredibly helpful in selecting just the right donor.
193
 
 Donor Egg Bank USA: this bank is essentially a network of egg donation programs in 
the USA.
194
 They offer both anonymous donors (yet adult photographs of these 
donors are provided) and identity-release donors. They do not charge a fee for 
registering for an account on their website, or for viewing donor profiles.
195
 Donor 
profiles seem to contain varying amounts of donor information. It is not, however, as 
comprehensive as what is provided at the Fairfax banks. Prospective parents may only 
seek treatment in California, New York or Canada. 
 Seattle Sperm Bank: this bank predominantly offers identity-release donors;196 there 
are only four anonymous donors available at the time of writing this section.
197
 It 
offers basic donor information freely, however, prospective parents wishing for 
detailed information must purchase such information. Audio interviews, baby 
photographs, extended profiles etc, individually cost $10 each. Alternatively, 
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prospective parents can pay $50 for an ‘All Access Pass Membership’, which includes 
three months of unlimited access to all information available about the donor.
198
 [see 
screenshots below] 
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 The Sperm Bank of California: this bank offers both anonymous and identity-release 
donors. It provides basic donor profiles (with relatively scant information compared to 
the previous USA agencies/banks that were searched), however, detailed information 
(found in ‘extended profiles’) and baby pictures have to be purchased at $40 each.199 
[See screenshot below] 
 
 
Apart from the Fairfax Egg Bank, the rest of the aforementioned USA gamete agencies/banks 
offer both anonymous and identity-release donors (barring the fact that some of these 
agencies/banks offer adult photographs for their ‘anonymous’ donors). For the purpose of this 
dissertation, it must be noted that while identity-release donors are meant to provide 
identifying information to the agency/bank so that donor-conceived children may request it 
upon reaching the age of 18, identity-release donors are effectively anonymous until such 
time. Therefore, all the donors offered at these agencies/banks can be considered as 
anonymous. Bearing this in mind, it can be seen that these agencies/banks still offer detailed 
donor information to prospective parents, often at an additional fee. This observation is proof 
that even when maintaining an anonymous donor program, it is still possible for a gamete 
agency/bank to offer prospective parents detailed donor information, either freely or at a fee. 
                                                          
199
 https://www.thespermbankofca.org/choosing-donor-0, accessed 28 October 2017. 
40 
 
Nota bene: Due to the fact that there is a severe shortage of gametes in Canada,
200
 Canadian 
agencies often import gametes from the USA. Fairfax Cryobank, Fairfax Egg Bank, Donor 
Egg Bank USA and Seattle Sperm Bank are examples of gamete banks that export their 
gametes to Canada. The USA is a convenient choice in this instance, mainly because it has 
effectively commercialised gamete donation and also provides a greater selection of 
donors.
201
 
 
3.5 Conclusion 
As can be observed from the analysis above, the UK, Canada and USA – countries that share 
the same basic values with South Africa’s legal system – deal with the provision of donor 
information rather differently to South Africa. Many gamete banks and agencies in these 
three countries, which operate within the context of donor anonymity (albeit at varying 
degrees) as South Africa does, choose to provide prospective parents with relatively detailed 
donor information on their own accord. The provision of detailed information can either be 
freely provided or at a fee. Nonetheless, these countries are prime examples for proving that 
gamete banks and agencies can provide detailed donor information without significantly 
compromising donor anonymity. Thus, it would seem prima facie that South African gamete 
banks and agencies can also do the same.  
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CHAPTER 4 – AN ANALYSIS OF SOUTH AFRICAN LAW: CAN SOUTH AFRICA 
PERMIT THE TRADE IN PERSONAL GAMETE DONOR INFORMATION? 
4.1 Introduction 
In the previous chapter, a legal analysis of the provision of gamete donor information was 
undertaken to gauge how the comparator countries, who share the same basic values with 
South Africa’s legal system, dealt with this phenomenon. While the Nurture case focusses on 
Additional Information, this dissertation explores the question of whether personal donor 
information can be traded in South Africa. In light of the Nurture case, personal information 
would include both Required Information and Additional Information. The chapter will start 
with providing the relevant law, followed by a summary of each of the papers filed in the 
Nurture case. Thereafter, the question of whether gamete banks and egg agencies (there are 
no sperm donation agencies as sperm can be easily donated and cryopreserved immediately 
in a sperm bank)
202
 can legally operate in South Africa. This question must necessarily be 
dealt with before determining whether a new business model (of selling personal gamete 
donor information) can be engaged. Lastly, the analysis will end with determining what 
impact the POPI Act will have on such a business model, once it fully comes into force. 
4.2 Relevant law 
The following laws and regulations, which are stated verbatim, are provided for ease of 
reference: 
4.2.1 The NHA  
Payment in connection with the importation, acquisition or supply of tissue, blood, blood 
products or gametes 
60. (1) No person, except-  
(a) a hospital or an institution contemplated in section 58(l)(a), a person or an institution 
contemplated in section 63 and an authorised institution or, in the case of tissue or 
gametes imported or exported in the manner provided for in the regulations, the 
importer or exporter concerned, may receive payment in respect of the acquisition, 
supply, importation or export of any tissue or gamete for or to another person for any 
of the purposes contemplated in section 56 or 64; 
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(b) a person or an institution contemplated in section 63 or an authorised institution, may 
receive any payment in respect of the importation, export or acquisition for the supply 
to another person of blood or a blood product.  
(2) The amount of payment contemplated in subsection (1) may not exceed an amount which 
is reasonably required to cover the costs involved in the importation, export, acquisition or 
supply of the tissue, gamete, blood or blood product in question. 
(3) This section does not prevent a health care provider registered with a statutory health 
professional council from receiving remuneration for any professional service rendered by 
him or her. 
(4) It is an offence for a person- 
(a) who has donated tissue, a gamete, blood or a blood product to receive any form of 
financial or other reward for such donation, except for the reimbursement of 
reasonable costs incurred by him or her to provide such donation; and  
(b) to sell or trade in tissue, gametes, blood or blood products, except as provided for in 
this Chapter 
(5) Any person convicted of an offence in terms of subsection (4) is liable on conviction to a 
fine or to imprisonment for a period not exceeding five years or to both a fine and such 
imprisonment. 
 
4.2.2 The Regulations 
Compensation in respect of the withdrawal or removal of gametes 
5. A person from whose body a gamete has been removed or withdrawn may be reimbursed 
for any reasonable expenses incurred by him or her in order to donate a gamete as 
contemplated in section 60(4)(a) of the Act.
203
 
… 
Gamete donor files, availability of information and destruction of gametes 
9. (1) The competent person must immediately record the following information and 
documents in the gamete donor's file before a gamete is removed or withdrawn- 
(a) the gamete donor's - 
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(i) full name, surname, date of birth and identity number; 
(ii) age, height, mass, eye colour, hair colour, complexion, population group, 
nationality, sex, religion, occupation, highest educational qualification and 
fields of interest;  
(iii) family history referred to in regulation 8(i); and 
(iv) subject to regulation 7(a), wishes in respect of the number of artificial 
fertilisations for which her or his gametes may be used; 
(b) the particulars of medical tests for genetically transmissible disorders or for infectious 
diseases, or genetic evaluation of the gamete donor; 
(c) particulars of any evaluation of the psychological suitability of the gamete donor to 
donate a gamete; 
(d) particulars of each donation of gametes made by the gamete donor, including the date 
on which the donation of gametes was made; 
(e) the informed consent and documents contemplated in regulation 8(e); 
(f) results of the tests and the analysis or examination contemplated in regulation 8(e) to 
(g); and 
(g) any other relevant document or information that the competent person may request. 
  
(2) The competent person- 
(a) must retain the gamete donor file in safe-keeping and may not destroy the file, except 
with the written permission of the Director-General; 
(b) must make the particulars set out in sub-regulation (1)(a)(ii), (iii) and (iv), (b),(c) and 
(f), together with the identification number referred to in regulation 8(a), available to 
the recipient and the competent person who is to effect the artificial fertilisation of the 
recipient; 
(c) must furnish the central data bank before 31 January of each year with the following 
particulars regarding the preceding year in respect of the gamete donor: 
(i) the identification number of the gamete donor file; 
(ii) the number of donations of gametes, with the dates on which the donations were 
made; and  
(iii) the number of live births reached through the artificial fertilisation from the 
gametes of the specific gamete donor; 
(d) must not make the gamete donor file, or information there from, available to any 
person other than a person acting under her or his supervision, except in terms of 
legislation or a court order; 
44 
 
…. 
Prohibition of Disclosure of certain facts 
19. No person may disclose the identity of any person who donated a gamete or received a 
gamete, or any matter related to the artificial fertilisation of such gametes, or reproduction 
resulting from such artificial fertilisation except where a law provides otherwise or a court so 
orders. 
 
4.3 The Nurture case 
The papers filed in the Nurture case will be individually summarised. Kindly note that the 
case makes reference to the Regulations (GN R175/2012) before it was amended in 2016. 
While the current amended Regulations (GN R1165 GG 40312) do not significantly alter the 
arguments in this case, it is still worth noting that the regulations applicable to the case have 
merely changed regulation numbers. For instance, regulation 8 in the case is in fact the 
current regulation 9. For the purposes of this dissertation, any regulations referred to in the 
case will be referred to as per the current Regulations. 
 
4.3.1 Notice of motion 
Nurture gave notice to the respondents that it intended to apply to Court to have it declared 
that Additional Information falls outside the ambit of section 60 of the NHA and regulation 5 
of the Regulations.
204
 
 
4.3.2 Founding affidavit 
The application concerned the question of whether gamete banks could provide Additional 
Information at a profit in South Africa.
205
 Nurture claimed that there is a development 
amongst international gamete banks in response to market demand – the provision of 
Additional Information to prospective parents.
206
 South African sperm banks, however, do 
not offer Additional Information, causing some South African prospective parents to incur 
great costs in order to import sperm from international sperm banks that offer Additional 
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Information.
207
 Nurture averred that in jurisdictions that ban the trade in gametes, like South 
Africa, there exists a business model whereby prospective parents can freely access basic 
donor profiles on a given donor database, but must pay for access to extra (optional) donor 
information.
208
 Nurture is an egg donation agency, however, it had plans of establishing an 
egg bank that would be independent of any fertility clinic.
209
 This plan included 
implementing the international business model of providing Required Information (either 
freely or on a cost-recovery (non-profit) basis), but providing prospective parents access to 
Additional Information at a cost that would allow the bank to gain a profit from such a 
sale.
210
 As the concept of trading in Additional Information raised a res nova, Nurture felt 
that it was prudent to first seek legal certainty on the matter before expending significant time 
and financial resources on its intended business plan.
211
 
In terms of the bank-customer relationship, Nurture argued that the implication of section 60 
of the NHA was that a gamete bank (which is recognised as an authorised institution) could 
only receive payment to cover its reasonable costs in return for the provision of gametes.
212
 
Similarly, with regard to the bank-donor relationship, donors are only entitled to be 
reimbursed for the reasonable costs they incurred in donating.
213
 From both these instances, it 
can be seen that the transaction is subject to a cost-recovery regime ie no profit can be 
derived from the transaction.
214
 It was argued that this, however, is only the case where the 
object of the transaction happens to be gametes, and not information about the gamete 
donor.
215
  
Furthermore, with regard to regulations 9(2)(b)-(c) of the Regulations and any sub-
regulations they cross-reference, Nurture stated that there was a range of specific information 
that was legally required from the gamete donor ie Required Information.
216
 This Required 
Information is, therefore, vital in any transaction where gametes are the object of the 
transaction.
217
 Also, Nurture acknowledged that donor anonymity is protected by regulation 
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19 of the Regulations.
218
 However, Nurture argued that Additional Information clearly falls 
outside the ambit of regulation 9(2)(b)-(c) and does not generally disclose the donor’s 
identity.
219
 As such, Additional Information can be legally disclosed to prospective parents.
220
 
Nurture referred to regulation 5 of the Regulations, and argued that the phrase ‘in order to 
donate a gamete’ pointed to acts that a donor was legally required to perform apart from the 
actual donation itself ie undergo specific medical tests and provide Required Information.
221
 
Therefore, in order for a donor to donate, the aforesaid acts must necessarily be performed 
and consequently, a donor must be reimbursed for any costs incurred in performing these 
acts. In contrast, however, the donor’s provision of Additional Information is not legally 
required in order to donate a gamete, and therefore, is not subject to regulation 5 of the 
Regulations.
222
 As such, it was argued that a donor may be compensated for any amount 
agreed upon (between the donor and the bank) for the provision of Additional Information, 
even if this amount surpasses a reasonable expense.
223
 Likewise, the bank may sell this 
information to prospective parents for any amount agreed upon.
224
 
In conclusion, Nurture stated that Additional Information falls outside the scope of the NHA 
and the Regulations, and hence, a gamete bank is allowed to trade in Additional Information. 
 
4.3.3 Answering affidavit 
The respondents opposed Nurture’s application on five grounds: First, the respondents 
opposed the application on the ground that the distinction between ‘hard-type’ and ‘soft-type’ 
information
225
 is cosmetic and, therefore, legally non-existent.
226
 This argument was simply 
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put forward without much elaboration, therefore, nothing further will be mentioned about it 
for now.  
Secondly, the respondents alleged that the legally non-required information contained in the 
donor file is prohibited from disclosure to anyone apart from a person supervised by a 
competent person.
227
 The respondents argued that, as per regulation 9(1)(g) of the 
Regulations, a competent person can record ‘any other relevant document or information that 
the competent person may request’;228 this information supposedly may include Additional 
Information.
229
 In addition to this argument, the respondents claimed that regulation 9(1)(g) 
read in conjunction with regulation 9(2)(d) prohibits the competent person from making the 
donor file, or information contained within the file, available to any other person (including 
the gamete recipient).
230
 The exception to the prohibition of disclosure is applicable only 
when the disclosure is made to a person acting under the competent person’s supervision, or 
as per legislation, or if a court order requires such disclosure.
231
  
Thirdly, the respondents urged the Court to exercise its discretion against the applicant 
because granting in the applicant’s favour may unduly cause vulnerable and poor women to 
donate their eggs by foregoing informed consent in response to the temptation of financial 
reward.
232
 The respondents claimed that certain South African egg donation agencies, who 
were not working with South African fertility clinics, recruited donors for the sole purpose of 
having them travel abroad to donate their gametes; large sums of money were provided to 
donors as an incentive.
233
 Some of these donors returned to South Africa in poor health as a 
result of receiving sub-standard medical treatment abroad.
234
 It was argued that if egg 
donation became a profit-driven business, bearing in mind that South Africa is subject to high 
levels of poverty and unemployment, poor women would easily be enticed to become donors 
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while having less regard for the medical risks associated with donation.
235
 For these further 
reasons, the respondents urged the Court to exercise its discretion against Nurture.
236
  
Fourthly – and perhaps the most important argument rendered by the respondents – it was 
argued that gametes and gamete donor information are inextricably linked, therefore, trading 
information contained in the donor file is tantamount to trading in gametes.
237
 This subjects 
the trade in information to the same sanctions as the trade in gametes.
238
 
Fifthly, the respondents argued that gamete banks are not supposed to be profit-driven 
business enterprises, but rather part of medical practice in general.
239
 
The respondents did, however, state that trade in Additional Information should be allowed 
before the harvesting of the eggs from the donor.
240
 However, it was argued that trade in 
Additional Information is prohibited after the eggs have been harvested from the donor.
241
 
The reason for this argument was that prior to harvesting the eggs, the information is about 
the gamete donor; after harvesting the eggs, the information ceases to be about the donor and 
is rather about the gamete itself.
242
 The respondents argued that Additional Information only 
retains its value in relation to the supply or acquisition of a gamete.
243
 In other words, 
information pertaining to harvested gametes is inextricably linked to the gametes themselves, 
and consequently has no value in the absence of the gametes.
244
 Therefore, an authorised 
institution and donor cannot derive profit from such a transaction.
245
 The implication then is 
that actual gamete donation and the profit derived from the trade in Additional Information 
are tantamount to the same transaction; this means that if trading in gametes is banned, then 
so is the trading of any information relating to the gametes.
246
 
The respondents’ expert, Prof John Anthony, the Head of Maternal and Fetal Medicine Unit 
in Groote Schuur Hospital and Associate Professor in the Department of Obstetrics and 
Gynaecology at the University of Cape Town, reiterated the arguments based on the five 
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grounds put forward in the answering affidavit. However, he elaborated further on the 
argument that gametes and gamete donor information are inextricably linked, therefore, 
trading information contained in the donor file is tantamount to trading in gametes. 
For one, he argued that the medical field is based upon principles that differ from the 
business field and even general society.
247
 With regard to determining the legality and 
morality of human transactions, he stated that the circumstances of the transactions are 
crucial because what may be acceptable in general society may not be acceptable as a 
medical transaction.
248
 As such, trading in Additional Information can only acceptable so 
long as it remains within the ambit of civil transaction; the moment it enters the arena of 
medical practice, it is no longer permissible to trade in Additional Information with a profit-
oriented agenda.
249
 He argued that, ultimately, what determines whether trading in donor 
information should be permissible is whether it falls within scope of a civil or medical 
transaction.
250
 
Prof Anthony stated that the application can actually be regarded as two separate 
applications: one, trading in donor information prior to medical procedure of harvesting the 
eggs, and two, trading in donor information after the medical procedure has begun.
251
 In other 
words, the first scenario does not entail any medical intervention because it is simply a 
transaction between the donor and recipient;
252
 the second scenario, however, entails the 
trading of information concerning harvested eggs which are stored in an egg bank as a direct 
result of medical practice.
253
 Furthermore, after harvesting, the information ceases to be about 
the donor but is rather about the gamete.
254
 This is because the information regarding the 
gametes only retains its value in conjunction with the gametes themselves. Therefore, trading 
in gamete information is prohibited by the same trade ban applicable to gametes themselves; 
they are one and the same transaction.
255
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4.3.4 Replying affidavit 
With regard to the four grounds the respondents argued to oppose the relief sought by the 
applicant, the applicant answered as follows: 
a) The distinction between hard-type and soft-type information was used in an 
explanatory fashion and is not the basis for the application – the application is hinged 
on the difference between Required Information and Additional Information.
256
 
b) The Regulations257 restrict the competent person (who keeps the donor file) from 
disclosing any information contained within the file; in no way do the Regulations – 
or any other legislation for that matter – prohibit the donor from sharing his/her 
personal information contained in the donor file,
258
 or place a restriction on the 
content of donor information that should be disclosed.
259
 Nor does the competent 
person’s restriction have anything to do with a gamete bank’s provision of donor 
information.
260
 This is because the gamete bank does not obtain such information 
from the competent person, but directly from the donor herself.
261
 Information, being 
intangible in nature, can exist in various places at any one time.
262
 While no one may 
access the donor file, this does not mean that no one can have access to the donor 
information outside the donor file.
263
 It would seem illogical to prohibit a donor from 
ever using the information commercially that s/he provided to the competent 
person.
264
 So long as the donor’s anonymity is maintained, there is no reason as to 
why a donor cannot enter into an agreement with the egg bank to provide her personal 
information for commercial use (without, of course, compromising donor 
anonymity).
265
  
c) Essentially, the respondents averred that providing poor female donors with 
remuneration for the provision of Additional Information, arguably at a profit, would 
compromise their autonomy when deciding to donate their eggs because they would 
disregard the risks associated with egg donation in response to the temptation of 
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money.
266
 Apart from the fact that medical complications occurring as a consequence 
of egg donation are a rarity,
267
 the reality in South Africa concerning the remuneration 
amount would constitute a compromise in autonomy as well.
268
 As per SASREG’s 
Guidelines, an egg donor’s reasonable costs are considered to be R7000.269 With egg 
donors being paid R7000, as a general rule, this could be regarded as a considerable 
amount of money for a poor person.
270
 Therefore, providing some profit for the 
provision of Additional Information would hardly be of consequence.
271
 In any event, 
there are two ways in which undue enticement can be prevented, instead of using the 
paternalistic approach of simply prohibiting the trade in Additional Information.
272
 
The first solution is to strengthen and enhance the informed consent mechanism to 
promote donor autonomy.
273
 Donors must be made aware of possible risks (medical 
and emotional) concerning donation, even if the possibility of these risks materialising 
being low.
274
 This can be done by the state creating regulations concerning the issue 
of donor-counselling.
275
 Alternatively, the state (or SASREG) could issue guidelines 
concerning informed consent procedures. The second solution would simply be to 
offer donors a modest compensation for their provision of Additional Information.
276
  
d) The prohibition of trade in gametes does not include the prohibition of trade in donor 
information.
277
 Conceptually, gametes and gamete donor information are factually 
related, however, they are undoubtedly distinguishable.
278
 Prospective parents may 
access donor information about a specific donor, but may choose not to purchase that 
specific donor’s gametes.279 What is important to note at this juncture, is that both 
Required Information and Additional Information constitute personal information of 
the donor – not the gamete.280 For instance, as was argued by the applicant, ‘a gamete 
does not have education, family history, personal and physical characteristics, et 
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cetera’.281 Any transaction relating to donor information cannot be the same as a 
transaction (acquisition, supply, importation or export) concerning gametes.
282
 
Consequently, it was argued that it is rather illogical to state that the same donor 
information can be traded before harvesting, but not after.
283
 Furthermore, the 
applicant stated that donor information does not change simply because a medical 
process has commenced.
284
 The applicant used the following analogy: ‘A photo of an 
actress is intrinsically linked to the actress, but the photo is not the actress. 
Accordingly, although the actress’s body is extra commercium, the photo is intra 
commercium. The same applies to gametes and donor information: While gametes are 
extra commercium, donor information is intra commercium.’285  
A second argument is that reading the statutory ban on the trade in gametes to include 
donor information is far too broad.
286
 This overly-broad interpretation would imply 
that all commercial acts that have a factual relationship with, but do not amount to, 
any transaction concerning gamete donation is illegal.
287
 Examples of such 
commercial activities that were used by the applicant include ‘(a) the laboratory 
consumables supplier that provides the plastic straws in which the gametes are kept, 
and (b) the courier service that handles the transport of gametes.’288 This, clearly, was 
not the intention of the legislature.
289
 The intention of the legislature is to simply ban 
the trade in gametes.
290
 
e) Lastly, the applicant denied that an egg bank is a species of medical practice; while it 
admitted that certain aspects of medical practice are necessarily part of an egg bank’s 
function, an egg bank is not a medical practice itself.
291
 A gamete agency or bank is a 
facility that provides donor information which prospective parents use to select a 
donor (a non-medical aspect), recruits donors (also a non-medical aspect) and 
coordinates an assortment of medical services pertaining to gamete donation.
292
 
Wanting to provide Additional Information as a competitive advantage is a business 
                                                          
281
 Replying affidavit para 275.2 p57. 
282
 Replying affidavit para 41 p12. 
283
 Replying affidavit para 153 p34. 
284
 Replying affidavit para 156 p35. 
285
 Replying affidavit para 214 p45. 
286
 Replying affidavit para 42 p12. 
287
 Replying affidavit para 42 p12. 
288
 Replying affidavit para 42 p12. 
289
 Replying affidavit para 42 p12. 
290
 Replying affidavit para 79 p19. 
291
 Replying affidavit para 21 p7. 
292
 Replying affidavit para 29 p9. 
53 
 
decision.
293
 Not only would Additional Information be an advantage for a gamete 
bank, but it also allows prospective parents to optimally exercise their autonomy by 
making an informed decision for, with all the information that is available to them.
294
 
While there are clearly some aspects of the egg donation process that are clearly of a 
non-medical nature, not all aspects are as they do not require a doctor-patient 
relationship.
295
 Cryopreserved eggs may be stored in an egg bank as a direct 
consequence of medical practice, but this does not imply that the egg bank (or egg 
agency for that matter) itself is a medical practice.
296
 As such, it does not follow that 
the permissibility of the practice is determined by whether it falls within the ambit of 
a civil or medical transaction.
297
 
 
4.4 Is it, in principle, legal to operate an egg donation agency and/or gamete bank in South 
Africa? 
As per section 60(1)(a) of the NHA, a gamete bank would only be allowed to function legally 
if it is first deemed to be an ‘authorised institution’. According to this section, only an 
authorised institution may receive payment for any transaction (acquisition, supply, 
importation or export) concerning gametes. As such, a gamete bank – if it is an authorised 
institution – falls squarely into this section as it acquires and supplies gametes. Furthermore, 
the terms ‘freezing or cryopreservation’ are defined in the Regulations as ‘freezing or 
cryopreserving genetic material including ova, sperm, embryos, ovarian tissue or stem cells 
by an authorised institution’298 [own emphasis]. As freezing or cryopreservation is generally 
executed by a gamete bank, this would imply that a gamete bank must first be an authorised 
institution before operating as such.
299
 Egg donation agencies, on the other hand, are not 
covered by section 60(1)(a) of the NHA (or any other legislation for that matter) because 
agencies do not engage in any transactions with eggs – an agency’s role is simply to match 
prospective parents with potential donors. That being said, all egg agencies in South Africa 
are SASREG-accredited.
300
 The risk for an egg agency not being SASREG-accredited, 
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however, is that an accredited fertility clinic may boycott it. Nonetheless, it is not legally 
mandatory for agencies to be SASREG-accredited. 
 
4.5 A critique on the respondents’ arguments and a conclusion concerning the issue of 
whether selling personal gamete donor information is legal in South Africa 
With regard to the respondents’ first argument – the distinction between ‘hard-type’ and 
‘soft-type’ information is cosmetic and, therefore, legally non-existent – this argument was 
swiftly nullified by the applicant simply because this allegation stood without much 
elaboration and was a feeble attempt to distract the Court from what was actually being 
argued by the applicant – the difference between Required Information and Additional 
Information. Essentially, the respondents’ first argument was a non-argument and already 
gave the indication that the respondents’ were opposing the matter for the sake of opposing it. 
The second argument – legally non-required information contained in the donor file is 
prohibited from disclosure to anyone apart from a person supervised by a competent person – 
was yet again a misinterpretation of the applicant’s argument. It should have been obvious to 
the respondents that the information would be retrieved by the bank from the donor herself 
and placed on a donor database where recipients can access it directly; this aspect clearly has 
nothing to do with the competent person (doctor) at all. The applicant had already argued 
extensively in its founding affidavit as to why a gamete bank and a donor should be free to 
contract as they wished regarding Additional Information, and consequently why the bank 
and the recipient could similarly contract (of course without compromising donor 
anonymity).
301
 The applicant, in other words, was referring to the bank-donor and bank-
customer relationship, which is based upon a contractual agreement – there is no need for the 
doctor’s intervention in such an instance. Even if some Additional Information which the 
donor provides does overlap with the information contained in the donor file, the applicant 
rightly argued that there is only a restriction upon the competent person, and not the donor 
herself – from revealing such information. Yet even so, it seems that this possible overlap of 
information is still far-fetched. For argument’s sake, let us consider the respondents’ 
argument in this instance. The respondents argued that, as per regulation 9(1)(g) of the 
Regulations, a competent person can record ‘any other relevant document or information that 
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the competent person may request’ [own emphasis], which supposedly could include 
information that could be considered as Additional Information. I submit that the risk of this 
overlap occurring is highly unlikely for the following reason. Regulation 9(1) provides a list 
of information that a competent person must immediately record in the donor file. Of this list, 
some of the information recorded must necessarily be disclosed to a recipient because it is 
cross-referenced by regulation 9(2)(b).
302
 The remaining items on the regulation 9(1) list can, 
therefore, not be revealed to anyone, including a recipient.
303
 These remaining items, 
however, must be analysed in order to gauge the nature of the information that must be kept 
in the donor file without ideally being revealed. Consider the two screenshots below 
depicting regulation 9(1). The sub-regulations that are highlighted refers to information that 
must be revealed to a recipient, and the sub-regulations that are not highlighted refers to 
information that must be held in the donor file without ideally being revealed viz regulations 
9(1)(a)(i), 9(1)(d), 9(1)(e) and 9(1)(g). 
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Sub-regulation 9(1)(a)(i) refers to identifying donor information, which obviously cannot be 
revealed as it would contravene regulation 19 which protects donor anonymity; sub-
regulation 9(1)(d) refers to information regarding the actual donation of gametes and is a 
matter of fact; sub-regulation 9(1)(e) refers to informed consent and cross-references 
regulation 8(e)
304
 which refers to various instances where the donor’s informed consent is 
required before gamete donation can occur. Thus, a certain theme seems to be running 
through the information in the donor file that cannot be revealed – all this information is 
logically required for actual gamete donation to occur. In other words, gamete donation 
cannot occur if the donor’s identifying particulars, history of previous donations, and 
informed consent are not recorded. Furthermore, sub-regulation 9(1)(g) directs attention to 
other ‘relevant’ documents or information. Thus, the word ‘relevant’ must necessarily be read 
to refer to information that is necessarily required for actual gamete donation to occur. 
Therefore, there seems to be no logical reason as to why a competent person may request 
Additional Information, as such information is not required or ‘relevant’ for actual gamete 
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(iv) to particulars contemplated in regulation 9(2)(c) being submitted to the central bank’. 
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donation to occur. In other words, the reason behind the competent person requesting 
Additional Information would serve no real purpose. 
The respondents’ third argument – vulnerable and poor women may be unduly enticed by 
financial reward into donating their eggs, causing them to disregard the potential risks of egg 
donation – is prima facie a noble one. However, as the applicant rightly pointed, the current 
suggested remuneration for donors by SASREG is R7000, which is arguably a significant 
amount of money for a poor person in any event, thereby causing the profit for the provision 
of Additional Information to be of little consequence. What is noteworthy, however, is the 
applicant’s attempt to provide viable solutions to guard against undue enticement resulting 
from any profit that may be derived from the provision of Additional Information. The truth 
of the matter is, irrespective of what business endeavour one may pursue, challenges will 
always present themselves. The key, as illustrated by the applicant, is to first look for 
solutions that can satisfy as many stakeholders as possible as opposed to simply discarding 
the endeavour. If viable solutions are not utilised, it may adversely affect the competitiveness 
of a business. 
With regard to the respondents’ fourth argument – gametes and gamete donor information are 
inextricably linked, therefore, trading in such information is tantamount to trading in gametes 
which subjects the trade in information to the same sanctions as the trade in gametes – it can 
be acknowledged that this was a good argument prima facie and perhaps the best one 
proffered by the respondents. However, this argument was nullified by the applicant whose 
main counter-argument in this instance was shockingly simple and precisely on point that one 
wonders how the respondents did not see it in the first place – gametes do ‘not have 
education, family history, personal and physical characteristics, et cetera’,305 therefore, the 
information is necessarily and clearly about the donor. While initially being deceptively 
appealing, the respondents’ argument was destroyed by this one simple counter-argument, let 
alone all the other counter-arguments offered by the applicant in this instance. I further 
submit that the respondents’ assumption that donor information retains little significant value 
in the absence of the gametes themselves appears to be a reference to heritable donor 
characteristics. The only logical reason that can be assumed for the respondents’ stance that 
the information is actually about the gametes as opposed to the donor (after egg-harvesting), 
is because the gametes contain the potential of manifesting donor characteristics that are 
                                                          
305
 Replying affidavit para 275.2 p57. 
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described in a donor’s personal information; genetic heritability can be the only reason why 
the ‘inextricably linked’ argument can be offered. While this logic seems valid prima facie, 
donor information cannot actually be about the gametes for the following two additional 
reasons: first, no one knows exactly which 23 chromosomes are contained in a gamete, 
therefore, there is no guarantee that a potential offspring will inherit specific characteristics; 
secondly, characteristics that are potentially heritable are already described in the Required 
Information which is made available to recipients in any event. If a donor characteristic can 
never be heritable, then it has no direct link to the gamete as that gamete will never carry the 
potentiality of manifesting such a characteristic. Additional Information describes such 
uninheritable donor characteristics. As such, Additional Information cannot be inextricably 
linked to the gamete. 
With regard to the respondents’ argument that donor information can be traded before egg 
harvesting (the equivalent argument being that gametes must still be within the body of the 
donor when it is traded) but not after egg harvesting (the equivalent argument being that 
donor information cannot be traded once the gametes are out of the donor’s body), in 
conjunction with the argument that poor females would be enticed into donating their eggs in 
the name of profit-making, it appears that the respondents imply and concede that egg 
agencies (and sperm agencies, had there been any) are free to trade in Additional Information. 
This is because egg agencies must first match recipients to potential donors before the donors 
can donate. Gamete banks, on the other hand, are already in possession of donated 
cryopreserved gametes. However, being able to trade donor information before donation, 
rather than after donation, makes no sense in light of the respondents’ own argument – if 
donor information is inextricably linked to the gamete, then surely this supposed inextricable 
link exists whether the gamete is in the donor’s body or out of the donor’s body ie 
irrespective of whether donation has occurred or not. In any event, the applicant correctly 
argued that information cannot miraculously cease to be about the donor once medical 
procedures have begun. Donor information remains as donor information, irrespective of 
when it is traded, and cannot logically be about the gamete. However, one positive 
development from the respondents’ argument has emerged and can be seen as a point of 
consensus between the parties – although there is currently no consensus as to whether 
gamete banks can trade in Additional Information, it can at least be said that agencies are 
seemingly free to trade in Additional Information.  
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Lastly, the respondents’ fifth argument - gamete banks are not supposed to be profit-driven 
business enterprises, but rather part of medical practice in general – seems to be misguided. 
Before delving into this argument, it must be noted that gamete agencies can be and are 
clearly profit-driven enterprises; as recipient-donor ‘match-makers’, they are neither part of 
medical practice, nor are they governed by the any legislation discussed thus far. Gamete 
banks, however, do share some elements of medical practice but essentially they are 
businesses. Once again, the applicant pointed out a simple but undeniable fact – wanting to 
provide Additional Information as a competitive advantage is a business decision. Aside from 
this fact, it cannot be ignored that for-profit businesses do exist within the field of medicine. 
Furthermore, not every transaction by the recipient in the setting of an egg bank requires a 
doctor-patient relation, therefore, it cannot be said that an egg bank is a medical practice. 
In light of the above analysis, it can clearly be seen that trading in personal donor information 
is, in principle, legal in South Africa (both by agencies and banks) despite whether there is 
consensus or not. Furthermore, if it is legal to operate an egg agency and gamete bank in 
South Africa, then surely it is legally acceptable for such businesses to engage a business 
model that provides them with a competitive edge (as trading in personal donor information 
would). I am confident that, had judgment been passed in the Nurture case, the Court would 
have ruled in Nurture’s favour.  
 
4.6 How will the potential trade in gamete donor information be affected when the POPI Act 
comes into force? 
One of the main purposes of the POPI Act is to balance the right to privacy against the right 
to access information.
306
  While the protection of personal information, as the title of the 
POPI Act suggests, is the ultimate aim of this piece of legislation, nothing contained in it 
precludes the processing
307
 of personal information (particularly the collection, use and 
dissemination thereof) for the purpose of trade by gamete banks or agencies. In fact, with 
regard to some of the instances where personal information may be processed, section 
11(1)(f) of the POPI Act states that personal information can be processed if it ‘is necessary 
                                                          
306
 Section 2(a)(i) of the POPI Act. 
307
 According to section 1 of the POPI Act, the term ‘processing’ denotes ‘any operation or activity or any set of 
operations, whether or not by automatic means, concerning personal information, including— 
(a) the collection, receipt, recording, organisation, collation, storage, updating or modification, retrieval, 
alteration, consultation or use; 
(b) dissemination by means of transmission, distribution or making available in any other form; or 
(c) merging, linking, as well as restriction, degradation, erasure or destruction of information’. 
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for pursuing the legitimate interests of the responsible party or of a third party to whom the 
information is supplied’. Thus, when the POPI Act comes into force, this Act will not prevent 
a gamete bank and agency from pursuing the business model of trading personal gamete 
donor information. This, of course, is subject to the conditions that must be satisfied for the 
processing of personal information as per the POPI Act.
308
 As long as a gamete donor 
provides informed consent
309
 for the trade in his/her personal information and knows exactly 
why his/her information is being collected
310
 (which should necessarily be done irrespective 
of whether the POPI Act is in force or not) the POPI Act does not prevent a gamete bank or 
agency from contracting with donors and recipients for the purchase and sale of personal 
donor information respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
308
 These conditions are found in section 4(1) of the POPI Act. Some conditions include accountability, purpose 
specification, openness, security safeguards etc. 
309
 Section 27(1)(a) of the POPI Act. 
310
 Section 13(2) and 18(1)(c) of the POPI Act. 
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CHAPTER 5 – CONCLUSION 
At the beginning of this dissertation, the research problem put forward concerned the 
uncertainty surrounding trade in personal gamete donor information. This issue was placed in 
the context of the NHA expressly outlawing the trade in gametes (but not the trade in gamete 
donor information) as per section 60(4)(b), and the Regulations protecting donor anonymity 
as per regulation 19. The importance of addressing this issue lays in the fact that South 
African gamete banks and agencies will experience legal uncertainty if they wish to engage 
the business model of trading personal donor information similar to that of their overseas 
counterparts. Thus far, there has been no literature concerning trade in donor information, 
save for the Nurture case whose application was withdrawn after litis contestatio. As such, 
the dissertation sought to explore whether personal donor information could, in principle, be 
traded in South Africa. 
Of course, before considering if donor information could be traded, it was vital to establish 
why there is a need for Additional Information. In chapter two, it was noted that since having 
children formed an integral part of many people’s lives, news of infertility could serve as a 
devastating blow to such people. In the context of such complex losses, many people seek to 
fulfil their dreams of parenthood via IVF. It was seen that the importance of choosing a 
gamete donor overlaps greatly with the importance of choosing a life partner. Consequently, 
the role of extensive donor information in donor selection was examined. Ultimately, while 
various pros and cons to having Additional Information were found, it was argued that the 
overriding factor that should be considered is the bioethical principle of autonomy. Given that 
many prospective parents attach great significance to choosing their gamete donors, having 
access to extensive donor information to make a truly informed choice is vital. Admittedly, 
not all prospective parents may want Additional Information, however, the option of 
accessing such information should necessarily exist for those who do wish to have such 
information. 
For an international perspective, a comparative study was undertaken with the UK, USA and 
Canada in order to gauge how these countries dealt with the provision of donor information. 
While it was established that there is currently no country which regulates the trade in donor 
information, it was worth determining if there were any differences and/or similarities in the 
way donor information was provided in these countries, as compared to South Africa. Seeing 
that all the comparator countries protected donor anonymity (albeit at varying degrees) as 
South Africa does, many gamete banks and agencies in these countries still chose to provide 
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prospective parents extensive donor information on their own accord without compromising 
donor anonymity. Furthermore, some of these gamete banks and agencies provided a basic 
donor profile free of charge, while charging a fee for access to extensive donor information. 
This is in direct contrast to South Africa, where Nurture is the only agency to provide 
Additional Information.  
Chapter four, the crux of this dissertation, dealt with the analysis of the Nurture case and the 
relevant legislation. From this analysis, the conclusion drawn was that in principle, personal 
gamete donor information can be traded in South Africa. Furthermore, trade in personal 
gamete donor information will not be affected by the POPI Act. 
 
5.2 Recommendations 
5.2.1 Legislation – the NHA  
In order to create legal certainty as to whether South African gamete banks and agencies can 
engage in trade in personal gamete donor information, there needs to be a minor amendment 
in the NHA, particularly section 60(3): 
(3) This section does not prevent a health care provider registered with a statutory health 
professional council from receiving remuneration for any professional service rendered by 
him or her nor does this section prevent an authorised institution and gamete donor from 
receiving remuneration beyond reasonable costs incurred for the trade in non-identifying 
gamete donor information.  
 
5.2.2 Informed consent 
To guard against undue enticement of donors that may occur as a result of payment for 
Additional Information beyond reasonable expenses, there are two safeguard mechanisms 
that can be employed (as was suggested by the Nurture’s expert).  
Firstly, the informed consent mechanism must be strengthened and promoted. In other words, 
donors must necessarily be made aware of material risks that may materialise in the course of 
donation, irrespective of the nature (physical, psychological, emotional etc) or likelihood of 
occurrence of the risk. Such awareness can be ensured by the State issuing regulations 
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concerning donor-counselling. In fact, donor-counselling ought to be compulsory, whether or 
not a gamete bank or agency chooses to trade in Additional Information. The reason for this, 
once again, stems from the bioethical principle of autonomy. In chapter two of this 
dissertation, autonomy was hailed as the overriding factor in deciding whether Additional 
Information should be offered to prospective parents. The rationale behind this argument was 
that such information could be of assistance in helping prospective parents make a truly 
informed decision concerning their choice of donor. In a similar vein, gamete donors must 
also be given the opportunity to make a truly informed decision as to whether they would like 
to donate their gametes, notwithstanding any material risks involved in the donation. Thus, 
donors should be able to decipher if taking such risks are worth the profit they could make 
from selling their Additional Information. Standard counselling sessions need not exceed a 
single session to educate a donor about the material risks involved. This session should be 
provided at the gamete bank’s or agency’s cost, which can then be recouped from the fees 
charged to the relevant prospective parents. If the donor feels s/he needs additional 
counselling, this must be done at his/her own cost. Although prospective parents would 
ultimately bear the cost of the single counselling session, it should be seen as a matter of 
fairness to the donor. Donors must be educated about possible consequences of their 
donation, irrespective of whether there is trade in Additional Information. If the State is 
unable to issue regulations, the alternative would be to have the State (or SASREG) issue 
guidelines concerning informed consent procedures. The issue with guidelines, however, is 
that they lack legal force. Therefore, guidelines should be seen as a secondary resort. 
An additional solution is to simply offer donors a modest compensation for their provision of 
Additional Information. This can be done by SASREG recommending an agreed amount for 
Additional Information, as it has done for the reimbursement of reasonable expenses 
incurred. 
 
5.3 Areas for further research 
The topic of this dissertation is arguably a novel one; apart from the Nurture case, there has 
not been any literature concerning this area. Furthermore, the majority of the sources referred 
to in this dissertation are not of South African origin. Thus, there seems to be a paucity of 
research in the field of IVF from a South African legal perspective. It is suggested that more 
research regarding donor reimbursement be done, particularly in light of SASREG’s R7000 
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recommendation. Moreover, the question of what exactly constitutes ‘reasonable expenses 
incurred’ should be investigated. Currently, it is unknown as to how the figure of R7000 was 
decided upon by SASREG. Additionally, competition law must be considered in order to 
decide if SASREG is behaving anti-competitively. Have SASREG and other fertility clinics 
formed a cartel by deciding upon a random figure (R7000) for donor reimbursement? Of 
course, it is necessary to engage in empirical research. Thus, there should be an investigation 
into what South African donors’ actual reasonable costs are on average, in order to suggest a 
relatively more accurate figure for donor reimbursement for reasonable costs incurred as 
contemplated by section 60(4)(a) of the NHA. 
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